China Universal Asset Management Company’s Amneal Pharmaceuticals AMRX Stock Holding History

China Universal Asset Management Company’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$879K	Sell	50,773 -5,061	-9%	-$69.4K	0.05%	216
2026 Q1	$694K	Buy	55,834 +4,609	+9%	+$61.9K	0.05%	234
2025 Q4	$645K	Sell	51,225 -3,828	-7%	-$43.8K	0.05%	234
2025 Q3	$551K	Sell	55,053 -7,896	-13%	-$70.9K	0.05%	237
2025 Q2	$509K	Buy	62,949 +775	+1%	+$5.84K	0.05%	239
2025 Q1	$521K	Sell	62,174 -3,524	-5%	-$29.4K	0.05%	245
2024 Q4	$520K	Buy	+65,698	New	+$551K	0.05%	246

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

China Universal Asset Management Company's AMRX Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Amneal Pharmaceuticals (AMRX) stake by 9.1% in Q2 2026, selling an estimated $69.4K and leaving 50,773 shares worth $879K. The position accounts for 0.05% of the portfolio, ranked #216.

China Universal Asset Management Company first reported a position in AMRX in Q4 2024 and has held it in 7 quarters since. 306 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

China Universal Asset Management Company held 50,773 shares of Amneal Pharmaceuticals worth $879K as of Q2 2026.
China Universal Asset Management Company sold 5,061 Amneal Pharmaceuticals shares in Q2 2026, an estimated $69.4K.
Amneal Pharmaceuticals made up 0.05% of China Universal Asset Management Company's portfolio in Q2 2026, its #216 holding.
China Universal Asset Management Company first reported a position in Amneal Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
306 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.